Data Foundry

Drug recalls 2026

Rohto Cooling Eye Drops Max Strength — Class II drug recall D-0717-2026

Ongoing recall by Rohto-Mentholatum (Vietnam) Co., Ltd., reported 2026-07-29, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0717-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmRohto-Mentholatum (Vietnam) Co., Ltd., Ho Chi Minh, N/A, Vietnam
Recall initiated2026-07-14
Classified2026-07-23
Reported by FDA2026-07-29
DistributedNationwide (US)
Quantity499,673 cartons
Reason classessterility
UPC / GTIN / UDI-DI00310742011210
NDC10742-8158, 10742-8158-01, 10742-8158-02
Lot numbers2026/07, 2026/09, 2026/12, 2027/06, 2027/08, 2027/12, 2028/01, 2028/06, 2028/09, 2028/11, 2028/12, 2029/01, 2029/02, 3H1V, 3J2V, 4A1V, 4A1VA, 4G1V, 4I3V, 5A1V, 5B3V, 5G3V, 5J1V, 5L1V, 6A1V, 6B4V, 6C2V

Product

Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%), Sterile, TWIN PACK, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011210, NDC 10742-8158-2

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0717-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.